Clinical trial
Genetic and Epigenetic Contribution to Increased Risk of T2D in the UAE
NCT04270097 is registered in ClinicalTrials.gov with Imperial College London Diabetes Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic and Epigenetic Contribution to Increased Risk of T2D in the UAE
- Lead sponsor
- Imperial College London Diabetes Centre
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 23, 2016
- Completion date
- December 1, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.